Singapore, Singapore

Hirohisa Yano


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):

Title: Hirohisa Yano: Innovator in Hydrogel Technology

Introduction

Hirohisa Yano is a prominent inventor based in Singapore, known for his innovative contributions to hydrogel technology. His work focuses on the formation of hydrogels that can be utilized in various biomedical applications. With a single patent to his name, Yano's research has the potential to impact fields such as tissue engineering and drug delivery.

Latest Patents

Yano's patent, titled "Formation of hydrogel in the presence of peroxidase and low concentration of hydrogen peroxide," describes a process for creating hydrogels from a mixture that includes hydrogen peroxide, horseradish peroxidase, and a polymer with crosslinkable phenol groups. This innovative method allows for independent control over the gelation rate and crosslinking density of the hydrogel by adjusting the molarity of hydrogen peroxide and the concentration of horseradish peroxidase. The hydrogel can be tailored for applications such as cell growth and sustained delivery of therapeutic proteins, particularly in the treatment of liver cancer, fibrosis, or hepatitis.

Career Highlights

Hirohisa Yano is affiliated with the Agency for Science, Technology and Research, where he continues to advance his research in hydrogel technology. His work is characterized by a commitment to developing solutions that address significant medical challenges.

Collaborations

Yano collaborates with notable colleagues, including Motoichi Kurisawa and Li Wang, who contribute to his research endeavors and help enhance the impact of his innovations.

Conclusion

Hirohisa Yano's contributions to hydrogel technology exemplify the intersection of innovation and practical application in the biomedical field. His work not only advances scientific understanding but also holds promise for improving patient care through targeted therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…